FIELD: medicine.
SUBSTANCE: invention relates to field of medicine and pharmacology and deals with application of derivatives of aminospirits of formula
or their phosphate derivatives for manufacturing medication for treatment of various autoimmune diseases, such as disseminated sclerosis, peripheral nephritis, retrobulbar neuritis, amyotrophic lateral sclerosis and uveitis.
EFFECT: invention ensures high treatment efficiency.
7 cl, 2 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
TREATING AUTOIMMUNE DISEASES | 2006 |
|
RU2493840C2 |
S1P RECEPTOR MODULATORS FOR MULTIPLE SCLEROSIS TREATMENT | 2007 |
|
RU2617502C2 |
SIP RECEPTOR MODULATORS FOR TREATING MULTIPLE SCLEROSIS | 2007 |
|
RU2495664C2 |
MODULATORS OF RECEPTOR S1P FOR TREATMENT OF MULTIPLE SCLEROSIS | 2007 |
|
RU2569732C9 |
LIQUID COMPOSITIONS | 2006 |
|
RU2428180C2 |
LIQUID FORMULATIONS | 2006 |
|
RU2470631C2 |
USING SIP RECEPTOR MODULATOR | 2008 |
|
RU2498796C2 |
APPLICATION OF S1P RECEPTOR AGONIST AND METHOD OF TREATMENT, ALLEVIATION OR RETARDATION OF OPTIC NEURITIS OR DEMYELINATING DISEASES PROGRESSION | 2003 |
|
RU2391094C2 |
ORGANIC COMPOUNDS | 2003 |
|
RU2478378C2 |
COMBINATIONS WHICH INCLUDE RECEPTOR S1P AGONIST AND JAK3 KINASE INHIBITOR | 2005 |
|
RU2415678C2 |
Authors
Dates
2011-07-27—Published
2006-09-07—Filed